Dr. Reddy’s Laboratories Ltd ADR (RDY)

63.01
-0.17(-0.27%)
After Hours
61.45
-1.56(-2.48%)
- Real-time Data
  • Volume:
    131,781
  • Day's Range:
    62.68 - 63.32
  • 52 wk Range:
    49.79 - 63.45
Earnings results expected in 7 days

Dr. Reddy’s Labs ADR will announce its quarterly financial results in 7 days. Traders should take this into account as the share price often fluctuates around this time period.

RDY Overview

Prev. Close
63.18
Day's Range
62.68-63.32
Revenue
245.88B
Open
62.97
52 wk Range
49.79-63.45
EPS
271.43
Volume
131,781
Market Cap
10.57B
Dividend (Yield)
0.4144
(0.66%)
Average Vol. (3m)
230,368
P/E Ratio
19.20
Beta
0.23
1-Year Change
13.53%
Shares Outstanding
166,184,557
Next Earnings Date
Jul 26, 2023
What is your sentiment on Dr. Reddy’s Labs ADR?
or
Market is currently closed. Voting is open during market hours.

Dr. Reddy’s Laboratories Ltd ADR Company Profile

Dr. Reddy’s Laboratories Ltd ADR Company Profile

Employees
24795

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company’s Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyStrong BuyStrong Buy
Technical IndicatorsBuySellStrong BuyStrong BuyStrong Buy
SummaryBuyNeutralStrong BuyStrong BuyStrong Buy
  • guys hold for 18200 had some new work done
    0
    • opening
      0
      • 54
        1
        • 53 today
          0
          • what doing dr reddy stock why cresh stock plz idea ??????
            1
            • yesterday result lis not good
              0
          • dr reddy lab adr target ??????
            0
            • Dr.Reddy lab ADR will cross 75 by end october 2021. Slow and steady safe bet.
              1
              • Buy Dr. Reddy around 63 target 65
                0
                • friends plz suggest DRREDDY will reach 52 week low
                  1
                  • NOT AT ALL
                    0
                • pls suggest DRREDDY is short or long in short term
                  0
                  • long
                    0
                  • target
                    0